Newsroom

MADISON, N.J., August 13, 2020 – Merck Animal Health, known as MSD Animal Health outside the United States and Canada, in partnership with the Veterinary Entrepreneurship Academy (VEA) and VetPrep, today announced the winners of this year’s THE IDEA Student Innovation Competition. University of Georgia’s Alyssa Gutierrez and Greena Kim, and UC Davis’ Madison Luker […]

Read more

MADISON, N.J., August 10, 2020 – Merck Animal Health (known as MSD Animal Health outside the United States and Canada), today announced PORCILIS® ILEITIS is now approved for multi-dose administration to vaccinate against ileitis caused by Lawsonia intracellularis. Previously approved to be given as one 2 mL dose at three weeks of age, the new license […]

Read more

Strategic Transaction Enhances Farm-to-Table Animal Traceability Solutions for Livestock and Aquaculture MADISON, N.J., August 5, 2020 – Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today announced the completion of its acquisition of IdentiGEN, a leader in DNA-based animal traceability […]

Read more

Dear Merck Animal Health Customer, As the coronavirus disease (COVID-19) outbreak continues to unfold, I am reaching out to you – a valued partner – as Merck Animal Health continues to navigate this ever-evolving situation. First and foremost, the health and wellbeing of you, your loved ones, and our own employees remain our top priority. […]

Read more

New teat sealant designed for today’s dry cow management programs MADISON, N.J., January 10, 2020 – Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today launched ShutOut™, an easy-to-administer teat sealant for the prevention of new intramammary infections throughout the dry period – the timeframe when cows are at […]

Read more

Three-way vaccine offers longest duration of immunity against IBR MADISON, N.J., February 6, 2020 – Merck Animal Health (known as MSD Animal Health outside the United States and Canada) has introduced Nasalgen® 3, a three-way intranasal vaccine that protects beef and dairy cattle from the most common pneumonia-causing viral pathogens. Administering intranasal vaccines to neonatal calves […]

Read more

Results Presented at 2020 Veterinary Meeting & Expo ORLANDO, Fla., Jan. 18, 2020 – Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today announced the results of a comprehensive study of wellbeing and mental health among U.S. veterinarians, which are critical issues facing the veterinary profession. Conducted in collaboration […]

Read more

Extended Duration Formulation Ensures Cats Receive Broad-Spectrum Parasite Coverage in One Topical Application MADISON, N.J., Nov. 15, 2019 – Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA [NYSE: MRK], today announced the U.S. approval of BRAVECTO® PLUS topical solution for cats by the U.S. Food and Drug Administration (FDA). BRAVECTO PLUS […]

Read more